Delivery Order SPE2DB20D1100-SPE2DB25FD5T0
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,064.80 by the Defense Logistics Agency's Medical Supply Chain on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price contract, designated as a non-set-aside competitive award, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,439.40 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568932617) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,470.85 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive and scheduled for ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,980 on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is set to be completed by July 23, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,447.28 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,193.52 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025. This unset-aside, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,538.80 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,989.20 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 1,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,699.07 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,991.18 by the Defense Logistics Agency Medical Supply Chain on July 26, 2025. The contract, designated as a firm fixed price delivery order with no set-aside provisions, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5T0Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,024.74 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 22, 2025, for Trexall 10 mg tablets (30-count packages). This non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This award exemplifies AmerisourceBergen's role as a critical vendor within the DLA's pharmaceutical supply chain, supporting military and veteran healthcare systems. The company's federal procurement portfolio demonstrates consistent capability to deliver diverse pharmaceutical products ranging from specialty medications to generic drugs through competitive contracting mechanisms. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with the DLA planning future multiple-award Pharmaceutical Prime Vendor Global Program Generation V contracts across separate regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/22/25 |